Stock listing
Lenz Therapeutics, Inc.
Selected listing: LENZ · NASDAQ · USD · US
Lenz Therapeutics, Inc. (NASDAQ:LENZ), Health Technology. Latest release Aug 11, 2026: LENZ Therapeutics Reports Second Quarter 2026 Financial Results…
- Ticker
- NASDAQ:LENZ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Lenz Therapeutics, Inc.
The company focuses on developing innovative therapeutic solutions. Investors can find more information about its operations and performance on its public company page.
Latest news from Lenz Therapeutics, Inc.
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 11, 2026
LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
August 4, 2026
LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia
July 5, 2026
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
June 24, 2026
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
June 7, 2026
Events
Research Lenz Therapeutics, Inc.
Lenz Therapeutics, Inc. company profile
View the public company page for Lenz Therapeutics, Inc. on 6ix.
Lenz Therapeutics, Inc. news
Read company news and market updates connected to Lenz Therapeutics, Inc..
Lenz Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Lenz Therapeutics, Inc..